Donald Kenneth Chin, MD | |
1221 Highland Avenue, Clarkston, WA 99403 | |
(509) 758-5511 | |
Not Available |
Full Name | Donald Kenneth Chin |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 1221 Highland Avenue, Clarkston, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194885194 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MD00026793 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Donald Kenneth Chin, MD Po Box 189, Clarkston, WA 99403-0189 Ph: (509) 758-5511 | Donald Kenneth Chin, MD 1221 Highland Avenue, Clarkston, WA 99403 Ph: (509) 758-5511 |
News Archive
BioSante Pharmaceuticals, Inc. today announced that results of an evaluation of its 2A/Furin technology by Novartis Pharma AG in its industrial antibody CHO expression system were published in the Journal of Applied Microbiology & Biotechnology. The results demonstrate that the 2A/Furin technology was integrated successfully into a plasmid-based, industrial-scale, CHO antibody cell line development process, with minimal optimization required.
A human stem cell line derived from embryos that were identified by preimplantation genetic diagnosis (PGD) to carry the mutation for fragile X syndrome has provided an unprecedented view of early events associated with this disease.
Final results of the WIN-R trial,[1] the largest hepatitis C study conducted in U.S. patients, showed that weight-based REBETOL (ribavirin, USP) in combination therapy with PEG-INTRON (peginterferon alfa-2b) achieved significantly higher rates of sustained virologic response (SVR)[2] and lower rates of relapse compared to the combination therapy using a flat dose of ribavirin.
A new study from the University of Notre Dame shows drugs used to treat high cholesterol could interfere with the way breast cancer cells adapt to the microenvironment in the brain, preventing the cancer from taking hold.
Joshua Bederson, MD, Professor and System Chair for the Department of Neurosurgery at Mount Sinai Health System, is the first neurosurgeon to use CaptiView - a microscope image injection system from Leica Microsystems that overlays critical virtual reality imaging directly onto the brain when viewed through the eyepiece, known as the ocular, during surgery.
› Verified 7 days ago
Jagjit Mangat, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1221 Highland Ave, Clarkston, WA 99403 Phone: 509-758-5511 | |
Mr. Michael Driver, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1221highland Avenue, Clarkston, WA 99403 Phone: 509-758-5511 Fax: 509-751-9406 |